市場調査レポート

商品コード

1401985

心室補助装置の2030年までの市場予測：製品タイプ、フロータイプ、設計、用途、エンドユーザー、地域別の世界分析

Ventricular Assist Device Market Forecasts to 2030 - Global Analysis By Product Type, Type Of Flow, Design, Application, End User and By Geography

出版日: 2023年12月01日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 650,554円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,990円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 995,426円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,175,700円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、心室補助装置の世界市場は2023年に12億9,000万米ドルを占め、予測期間中にCAGR 12.8％で成長し、2030年には30億1,000万米ドルに達すると予測されています。

心室補助装置（VAD）と呼ばれる機械式ポンプは、弱ったり機能不全に陥ったりした心臓が全身に血液を送り出すのを助けるために、体内または体外に挿入されます。これらのデバイスは主に、心臓移植への橋渡し、移植に適さない患者の目的地治療、あるいは状況によっては重症心不全患者の回復への橋渡しとして使用されます。

世界保健機関（WHO）の2021年の発表によると、世界では毎年1,790万人が心血管系疾患で死亡していると推定されています。これは世界の死亡者数の35％に相当します。さらに、これらの心血管疾患による死亡の85％は心臓発作と脳卒中によるものです。

慢性疾患の急増

心不全を進行させる長期疾患の増加は、心室補助装置の需要を高める要因の一つです。心不全は糖尿病、高血圧、冠動脈疾患など多くの慢性疾患によって引き起こされる可能性があります。その結果、より多くの患者が高度な心臓治療を必要とするようになります。心不全の原因となる慢性疾患がより一般的になれば、心不全治療はより長期的で集中的なものとなります。このことは、心不全治療を無期限に必要とする患者や、心臓移植の適応とならない患者が増えることを意味し、市場の成長を促進します。

高コスト

心室補助装置治療には、フォローアップ治療、外科的処置、移植後のケア、装置使用料などの高額な費用がかかるため、患者の利用が制限される可能性があります。経済的な制約は、法外な出費のために特定の人々がこの救命療法にアクセスする妨げとなる可能性があります。地域や国によってヘルスケア制度や経済状況が異なるため、この治療法へのアクセスに格差が生じる可能性があります。さらに、医療インフラが貧弱な地域や財源が乏しい地域では、この治療法を必要としている人々に届けることが困難な場合があり、これが市場成長の妨げとなっています。

臓器不全のリスクの増加

高齢化、ライフスタイルの変化、慢性疾患の頻発などにより、臓器不全、特に心不全の可能性が高まっているため、心室補助装置やその他の高度な心臓補助療法に対する需要が高まっています。臓器不全、特に心不全のリスクが高まっているため、重篤な心疾患のリスクを抱える人が増えています。このような患者プールの拡大により、進行した心不全の治療にこの治療を必要とする人の数が増加します。

機器の信頼性と耐久性の低下

心室補助装置治療を選択する患者や医師の自信は、心室補助装置の耐用年数や信頼性に関する心配によって左右される可能性があります。装置の故障や誤作動を恐れるあまり、患者はこの治療法の選択をためらったり、消極的になったりする可能性があり、患者の受容性に悪影響を及ぼす可能性があります。さらに、心室補助装置技術の進歩を目的とした研究開発プロジェクトへの投資は、装置の信頼性と耐久性に関する永続的な懸念によって影響を受ける可能性があります。業界におけるイノベーションは、資金不足や新ガジェットの開発意欲の低下によって阻害され、市場の成長を阻害する可能性があります。

COVID-19の影響

多くの病院やヘルスケア機関は、流行のピーク時にリソースを配分し、緊急性の高い症例を優先し、必要のない治療を抑制するという困難に直面しました。心室補助装置の植え込みや定期的な経過観察など、選択的な処置が延期または遅延され、市場に一時的な影響を与えた可能性があります。生産や配送を含む世界のサプライチェーンの混乱が、これらの部品や器具、関連機械の入手や輸送に影響を与えた可能性もあります。こうした不都合は、心室補助装置の購入や設置のタイミングに影響を与える可能性があります。

予測期間中、右心補助循環装置分野が最大となる見込み

右心室補助装置は、心臓の右心室をサポートするために特別に作られた心室補助装置（VAD）の一種で、右心室補助装置（RVAD）であるため、右心室補助装置セグメントは有利な成長を遂げると推定されます。RVADは一般に心臓の右側を補助することに重点を置いているが、他の心室補助装置は左心室（左心室補助装置、LVAD）または両心室（BiVAD）を補助するように設計されています。心室補助装置の現在進行中の研究と技術開発の目標は、患者の転帰を改善し、問題を減少させ、RVADの耐久性を強化する一方で、右心室の維持に特有の問題に対処することです。

予測期間中、植え込み型心室補助装置のCAGRが最も高くなる見込み

植え込み型心室補助装置分野は、予測期間中に最も高いCAGR成長が見込まれます。植え込み型心室補助装置（Implantable Ventricular Assist Devices：VADs）と呼ばれる機械式ポンプは、外科手術によって体内に挿入され、心臓が血液を送り出すのを助ける。重症の心不全患者や心臓移植を待つ患者に補助を提供するこれらの機器は、心室補助装置市場に欠かせない存在です。生活の質が向上し、運動能力が増強され、心不全症状が緩和され、重症心不全患者の生存期間が延長されます。

最大のシェアを占める地域

アジア太平洋地域では、高齢化、ライフスタイルの変化、心血管障害の増加により心不全が一般的になっているため、予測期間中、アジア太平洋地域が最大の市場シェアを占めると予測されます。治療の選択肢として心室補助装置の必要性が高まっているのは、心不全患者の増加の結果です。アジア太平洋地域のどの国も、最先端の心臓治療のための施設の近代化を含め、ヘルスケア・インフラの拡大に向けた投資を行っています。多くの大手医療機器メーカーが、アジア太平洋地域のこの市場への参入と成長に注力しています。

CAGRが最も高い地域：

予測期間中、欧州のCAGRが最も高いと予測されるのは、世界の他の多くの地域と同様、欧州でも心不全が一般化しているためです。心不全患者の増加に伴い、進行した心不全患者の治療オプションとして心室補助装置の必要性が高まっています。さらに、この技術は改良を重ね、現在では欧州市場でも入手可能となっています。絶え間ない技術革新は、患者の転帰を改善し、心室補助装置治療に関連する問題を低減し、よりコンパクトで堅牢かつ効果的な装置を生み出すことを目的としており、市場の成長を牽引しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様は、以下の無料カスタマイズオプションのいずれかを受けることができます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第11章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第12章企業プロファイル

Corewave SA
SynCardia Systems
AdjuCor GmbH
Bivacor Inc
LivaNova PLC
Windmill Cardiovascular Systems
Calon Cardio-Technology Ltd
Abiomed, Inc.
Fineheart
Abbott Laboratories
Evaheart, Inc.,
Berlin Heart GmbH
Carmat SA
Medtronic
Jarvik Heart, Inc.
ReliantHeart
Sun Medical Technology Research Corp
Thoratec Corporation
CardiacAssist, Inc

図表

List of Tables

Table 1 Global Ventricular Assist Device Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
Table 4 Global Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
Table 5 Global Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
Table 6 Global Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
Table 7 Global Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
Table 8 Global Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
Table 9 Global Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
Table 10 Global Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
Table 11 Global Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
Table 12 Global Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
Table 13 Global Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
Table 14 Global Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
Table 15 Global Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
Table 16 Global Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
Table 17 Global Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
Table 18 Global Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
Table 19 Global Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 20 Global Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
Table 21 Global Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
Table 22 Global Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 23 North America Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
Table 24 North America Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
Table 25 North America Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
Table 26 North America Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
Table 27 North America Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
Table 28 North America Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
Table 29 North America Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
Table 30 North America Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
Table 31 North America Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
Table 32 North America Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
Table 33 North America Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
Table 34 North America Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
Table 35 North America Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
Table 36 North America Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
Table 37 North America Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
Table 38 North America Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
Table 39 North America Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
Table 40 North America Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
Table 41 North America Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 42 North America Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
Table 43 North America Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
Table 44 North America Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 45 Europe Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
Table 46 Europe Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
Table 47 Europe Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
Table 48 Europe Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
Table 49 Europe Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
Table 50 Europe Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
Table 51 Europe Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
Table 52 Europe Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
Table 53 Europe Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
Table 54 Europe Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
Table 55 Europe Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
Table 56 Europe Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
Table 57 Europe Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
Table 58 Europe Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
Table 59 Europe Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
Table 60 Europe Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
Table 61 Europe Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
Table 62 Europe Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
Table 63 Europe Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 64 Europe Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
Table 65 Europe Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
Table 66 Europe Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 67 Asia Pacific Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
Table 68 Asia Pacific Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
Table 69 Asia Pacific Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
Table 70 Asia Pacific Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
Table 71 Asia Pacific Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
Table 72 Asia Pacific Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
Table 73 Asia Pacific Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
Table 74 Asia Pacific Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
Table 75 Asia Pacific Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
Table 76 Asia Pacific Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
Table 77 Asia Pacific Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
Table 78 Asia Pacific Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
Table 79 Asia Pacific Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
Table 80 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
Table 81 Asia Pacific Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
Table 82 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
Table 83 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
Table 84 Asia Pacific Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
Table 85 Asia Pacific Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 86 Asia Pacific Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
Table 87 Asia Pacific Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
Table 88 Asia Pacific Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 89 South America Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
Table 90 South America Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
Table 91 South America Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
Table 92 South America Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
Table 93 South America Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
Table 94 South America Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
Table 95 South America Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
Table 96 South America Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
Table 97 South America Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
Table 98 South America Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
Table 99 South America Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
Table 100 South America Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
Table 101 South America Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
Table 102 South America Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
Table 103 South America Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
Table 104 South America Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
Table 105 South America Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
Table 106 South America Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
Table 107 South America Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 108 South America Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
Table 109 South America Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
Table 110 South America Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 111 Middle East & Africa Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
Table 112 Middle East & Africa Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
Table 113 Middle East & Africa Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
Table 114 Middle East & Africa Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
Table 115 Middle East & Africa Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
Table 116 Middle East & Africa Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
Table 117 Middle East & Africa Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
Table 118 Middle East & Africa Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
Table 119 Middle East & Africa Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
Table 120 Middle East & Africa Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
Table 121 Middle East & Africa Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
Table 122 Middle East & Africa Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
Table 123 Middle East & Africa Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
Table 124 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
Table 125 Middle East & Africa Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
Table 126 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
Table 127 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
Table 128 Middle East & Africa Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
Table 129 Middle East & Africa Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 130 Middle East & Africa Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
Table 131 Middle East & Africa Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
Table 132 Middle East & Africa Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24505

According to Stratistics MRC, the Global Ventricular Assist Device Market is accounted for $1.29 billion in 2023 and is expected to reach $3.01 billion by 2030 growing at a CAGR of 12.8% during the forecast period. A mechanical pump called a Ventricular Assist Device (VAD) is inserted either within or outside the body to help a weak or failing heart pump blood throughout the body. These devices are mostly used as a bridge to heart transplantation, destination treatment for patients not suitable for transplantation, or, in certain circumstances, as a bridge to recovery in patients with severe heart failure.

According to the World Health Organization 2021, an estimated 17.9 million people die due to cardiovascular diseases worldwide, each year. This represents 35% of global deaths. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke.

Market Dynamics:

Driver:

Surge in the prevalence of chronic conditions

An increase in long-term illnesses that lead to advanced heart failure is one factor driving up demand for ventricular assist device. Heart failure can be caused by a number of chronic illnesses, including diabetes, hypertension, and coronary artery disease. As a result, more individuals will need sophisticated cardiac care. Heart failure care may need to be longer and more intensive if chronic diseases that contribute to heart failure are more common. This may mean that more patients may need this therapy indefinitely, or that more patients who are not candidates for heart transplantation will need thus driving the growth of the market

Restraint:

High cost

Patients' access may be restricted by the high cost of ventricular assist device therapy, which includes follow-up therapies, surgical procedures, post-implantation care, and device fees. Financial limitations may impede certain persons from accessing this life-saving therapy because of its exorbitant expenses. Variations in healthcare systems and economic situations among various areas or nations may give rise to disparities in the accessibility of this treatment. Moreover, this treatment may be difficult to get to those in need in areas with a poor healthcare infrastructure or low financial resources which hamper the market growth.

Opportunity:

Increasing risks of organ failures

Ventricular Assist Device and other advanced cardiac support therapies are in greater demand as the chances of organ failures, particularly cardiac failure, and rise owing to aging populations, changing lifestyles, and the frequency of chronic illnesses. An increasing number of people are at risk for serious cardiac disorders due to the rising risks of organ failure, particularly heart failure. The number of people who would need this treatment to treat advanced heart failure rises as a result of this patient pool expansion.

Threat:

Compromised device reliability and durability

Patients' and doctors' confidence in selecting ventricular assist device therapy may be impacted by worries regarding the longevity and dependability of the device. Fear of device failure or malfunction may cause patients to hesitate or be reluctant to choose this treatment, which may have an adverse effect on patient acceptability. Furthermore, investment in R&D projects targeted at advancing VAD technology may be impacted by enduring worries about the dependability and durability of the devices. Innovation in the industry may be hampered by a lack of funding or a decline in enthusiasm in creating new gadgets impeding the market growth.

COVID-19 Impact

Many hospitals and healthcare institutions encountered difficulties in allocating resources, giving priority to urgent cases, and curtailing non-essential treatments during the peak times of the epidemic. It's possible that elective procedures, such as certain ventricular assist device implantations or regular follow-ups, were postponed or delayed, which momentarily affected the market. Disruptions in the worldwide supply chain, including production and delivery, may have affected the accessibility and conveyance of these parts, apparatus, or associated machinery. These hiccups can have an impact on when ventricular assist device are purchased and installed.

The right ventricular assist device segment is expected to be the largest during the forecast period

The right ventricular assist device segment is estimated to have a lucrative growth, as it one kind of Ventricular Assist Device (VAD) made expressly to support the right ventricle of the heart is the Right Ventricular Assist Device (RVAD). The RVAD is generally focused on helping the right side of the heart, while other VADs are designed to support the left ventricle (Left Ventricular support Device, or LVAD) or both ventricles (BiVAD). The goal of ongoing research and technological developments in VADs is to improve patient outcomes, decrease problems, and strengthen the endurance of RVADs while addressing issues unique to sustaining the right ventricle.

The implantable ventricular assist device segment is expected to have the highest CAGR during the forecast period

The implantable ventricular assist device segment is anticipated to witness the highest CAGR growth during the forecast period. Mechanical pumps called Implantable Ventricular Assist Devices (VADs) are surgically inserted within the body to help the heart pump blood. These devices, which provide assistance to those with severe heart failure or that awaiting heart transplantation, are an essential part of the market for ventricular assist devices. The quality of life is enhanced, exercise capacity is boosted, heart failure symptoms are relieved, and patients with severe heart failure have a longer chance of survival due to these devices.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period as heart failure is becoming more common in the Asia Pacific area as a result of aging populations, changes in lifestyle, and an increase in cardiovascular disorders. The increased need for ventricular assist device as a therapy option is a result of the rise in heart failure cases. Every nation in the Asia-Pacific area is making investments in the expansion of its healthcare infrastructure, including modernizing its facilities for cutting-edge cardiac treatment. A number of major medical device companies have been concentrating on joining and growing in the Asia Pacific this market.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, because heart failure is becoming more common in Europe, as it is in many other parts of the world. The need for ventricular assist device as a therapy option for individuals with advanced heart failure has increased as a result of the growth in heart failure cases. Moreover, this technology has been improving and is now available in the European market. Constant innovation aims to improve patient outcomes, lower problems related to VAD therapy, and create more compact, robust, and effective devices driving the growth of the market.

Key players in the market:

Some of the key players profiled in the Ventricular Assist Device Market include Corewave SA, SynCardia Systems, AdjuCor GmbH, Bivacor Inc, LivaNova PLC, Windmill Cardiovascular Systems, Calon Cardio-Technology Ltd, Abiomed, Inc., Fineheart, Abbott Laboratories, Evaheart, Inc.,Berlin Heart GmbH, Carmat SA, Medtronic, Jarvik Heart, Inc., ReliantHeart, Sun Medical Technology Research Corp, Thoratec Corporation and CardiacAssist, Inc

Key Developments:

In November 2023, Sun Medical Technology Research Corp. announced that it has received ¥2 billion in funding from Hi-Lex Corporation. The investor will hold 66.7% stake in the company through this transaction.

In September 2023, CorWave announces the grand opening of its manufacturing facility on the banks of the Seine, next to Paris. The company occupies over 2,400m² of production, laboratory, and office space, bringing together its headquarters, R&D center and its first manufacturing facility of almost 1,000m².

Product Types Covered:

Right Ventricular Assist Device
Left Ventricular Assist Device
Bi-Ventricular Assist Device
Total Artificial Heart

Type Of Flows Covered:

Pulsatile Flow
Continuous Flow

Designs Covered:

Implantable Ventricular Assist Device
Transcutaneous Ventricular Assist Device

Applications Covered:

Bridge-To-Recovery (BTR)
Destination Therapy
Bridge-To-Transplant (BTT)
Bridge To Candidacy Therapy

End Users Covered:

Hospitals
Home Care Setups
Ambulatory Care Center
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Ventricular Assist Device Market, By Product Type

5.1 Introduction
5.2 Right Ventricular Assist Device
5.3 Left Ventricular Assist Device
5.4 Bi-Ventricular Assist Device
5.5 Total Artificial Heart

6 Global Ventricular Assist Device Market, By Type Of Flow

6.1 Introduction
6.2 Pulsatile Flow
6.3 Continuous Flow

7 Global Ventricular Assist Device Market, By Design

7.1 Introduction
7.2 Implantable Ventricular Assist Device
7.3 Transcutaneous Ventricular Assist Device

8 Global Ventricular Assist Device Market, By Application

8.1 Introduction
8.2 Bridge-To-Recovery (BTR)
8.3 Destination Therapy
8.4 Bridge-To-Transplant (BTT)
8.5 Bridge To Candidacy Therapy

9 Global Ventricular Assist Device Market, By End User

9.1 Introduction
9.2 Hospitals
9.3 Home Care Setups
9.4 Ambulatory Care Center
9.5 Other End Users

10 Global Ventricular Assist Device Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Corewave SA
12.2 SynCardia Systems
12.3 AdjuCor GmbH
12.4 Bivacor Inc
12.5 LivaNova PLC
12.6 Windmill Cardiovascular Systems
12.7 Calon Cardio-Technology Ltd
12.8 Abiomed, Inc.
12.9 Fineheart
12.10 Abbott Laboratories
12.11 Evaheart, Inc.,
12.12 Berlin Heart GmbH
12.13 Carmat SA
12.14 Medtronic
12.15 Jarvik Heart, Inc.
12.16 ReliantHeart
12.17 Sun Medical Technology Research Corp
12.18 Thoratec Corporation
12.19 CardiacAssist, Inc

心室補助装置の2030年までの市場予測：製品タイプ、フロータイプ、設計、用途、エンドユーザー、地域別の世界分析

Ventricular Assist Device Market Forecasts to 2030 - Global Analysis By Product Type, Type Of Flow, Design, Application, End User and By Geography

COVID-19の影響

最大のシェアを占める地域

CAGRが最も高い地域：

無料のカスタマイズサービス：

本レポートをご購読のお客様は、以下の無料カスタマイズオプションのいずれかを受けることができます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の心室補助装置市場：製品タイプ別

第6章 世界の心室補助装置市場：フロータイプ別

第7章 世界の心室補助装置市場：設計別

第8章 世界の心室補助装置市場：用途別

第9章 世界の心室補助装置市場：エンドユーザー別

第10章 世界の心室補助装置市場：地域別

第11章 主な発展

第12章 企業プロファイル